TH
BioPorto A/S
THOXF · OTC
$0.15 +0.00% (+$0.00)
Market Cap 474.9M kr
P/E Ratio 55.53x
Div. Yield -
ROE 14.07%
Piotroski F-Score Weak
3/9Valuation
7 /100
Expensive P/S 12.82x
P/B 5.78x
P/E 55.53x
Growth
58 /100
Stable Book val. growth 3.62%
Rev. growth 11.54%
FCF growth N/A
Profitability
40 /100
Moderate Net margin 23.08%
Op. margin 130.67%
FCF margin 188.74%
Quality
35 /100
Average ROE 14.07%
ROA 7.85%
Asset turnover 0.34x
Debt
100 /100
Low Current ratio 4.09x
Int. coverage 108.55x
Debt/Equity 0.07x
Stability
69 /100
Stable Rev. volatility 5.14%
EPS volatility 18.34%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o THOXF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Carsten Buhl
Employees
46
Headquarters
Hellerup
Prihajajoči dogodki
19 NOV.
Earnings
Upcoming earnings report